Cargando…
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
IMPORTANCE: Meta-analyses suggest that corticosteroids may be associated with increased survival without cerebral palsy in infants at high risk of bronchopulmonary dysplasia (BPD) but are associated with adverse neurologic outcomes in low-risk infants. Whether this association exists in contemporary...
Autores principales: | Jensen, Erik A., Wiener, Laura Elizabeth, Rysavy, Matthew A., Dysart, Kevin C., Gantz, Marie G., Eichenwald, Eric C., Greenberg, Rachel G., Harmon, Heidi M., Laughon, Matthew M., Watterberg, Kristi L., Walsh, Michele C., Yoder, Bradley A., Lorch, Scott A., DeMauro, Sara B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167571/ https://www.ncbi.nlm.nih.gov/pubmed/37155165 http://dx.doi.org/10.1001/jamanetworkopen.2023.12277 |
Ejemplares similares
-
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
por: Jensen, Erik A., et al.
Publicado: (2019) -
Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial
por: Gentle, Samuel J., et al.
Publicado: (2023) -
Duration of Noninvasive Respiratory Support and Risk for Bronchopulmonary Dysplasia or Death
por: Gentle, Samuel J, et al.
Publicado: (2022) -
Association Between Early Antibiotic Exposure and Bronchopulmonary Dysplasia or Death
por: Flannery, Dustin D, et al.
Publicado: (2018) -
Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals
por: Bamat, Nicolas A., et al.
Publicado: (2019)